Literature DB >> 10508158

Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases.

Q L Deveraux1, E Leo, H R Stennicke, K Welsh, G S Salvesen, J C Reed.   

Abstract

Several human inhibitor of apoptosis (IAP) family proteins function by directly inhibiting specific caspases in a mechanism that does not require IAP cleavage. In this study, however, we demonstrate that endogenous XIAP is cleaved into two fragments during apoptosis induced by the tumor necrosis factor family member Fas (CD95). The two fragments produced comprise the baculoviral inhibitory repeat (BIR) 1 and 2 domains (BIR1-2) and the BIR3 and RING (BIR3-Ring) domains of XIAP. Overexpression of the BIR1-2 fragment inhibits Fas-induced apoptosis, albeit at significantly reduced efficiency compared with full-length XIAP. In contrast, overexpression of the BIR3-Ring fragment results in a slight enhancement of Fas-directed apoptosis. Thus, cleavage of XIAP may be one mechanism by which cell death programs circumvent the anti-apoptotic barrier posed by XIAP. Interestingly, ectopic expression of the BIR3-Ring fragment resulted in nearly complete protection from Bax-induced apoptosis. Use of purified recombinant proteins revealed that BIR3-Ring is a specific inhibitor of caspase-9 whereas BIR1-2 is specific for caspases 3 and 7. Therefore XIAP possesses two different caspase inhibitory activities which can be attributed to distinct domains within XIAP. These data may provide an explanation for why IAPs have evolved with multiple BIR domains.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508158      PMCID: PMC1171595          DOI: 10.1093/emboj/18.19.5242

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  184 in total

1.  Mechanisms of apoptosis.

Authors:  J C Reed
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

2.  Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis.

Authors:  C Guégan; M Vila; G Rosoklija; A P Hays; S Przedborski
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

3.  Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth.

Authors:  J Chen; W Wu; S K Tahir; P E Kroeger; S H Rosenberg; L M Cowsert; F Bennett; S Krajewski; M Krajewska; K Welsh; J C Reed; S C Ng
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

4.  Reciprocal expression of survivin and SMAC/DIABLO in primary breast cancer.

Authors:  A Mansour; M Nabil; R Ali-Labib; H Said; F Annos
Journal:  Med Oncol       Date:  2011-12-08       Impact factor: 3.064

5.  The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells.

Authors:  Ke Long Jin; Jeong-Yeol Park; Eun Joo Noh; Kwang Lae Hoe; Joo Hak Lee; Jong-Hyeok Kim; Joo-Hyun Nam
Journal:  J Gynecol Oncol       Date:  2010-12-31       Impact factor: 4.401

6.  The mitochondrial ARTS protein promotes apoptosis through targeting XIAP.

Authors:  Yossi Gottfried; Asaf Rotem; Rona Lotan; Hermann Steller; Sarit Larisch
Journal:  EMBO J       Date:  2004-03-18       Impact factor: 11.598

Review 7.  The kinder side of killer proteases: caspase activation contributes to neuroprotection and CNS remodeling.

Authors:  B McLaughlin
Journal:  Apoptosis       Date:  2004-03       Impact factor: 4.677

Review 8.  The protein structures that shape caspase activity, specificity, activation and inhibition.

Authors:  Pablo Fuentes-Prior; Guy S Salvesen
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

9.  The BIR domain of IAP-like protein 2 is conformationally unstable: implications for caspase inhibition.

Authors:  Hwain Shin; Martin Renatus; Brendan P Eckelman; Viviane A Nunes; Claudio A M Sampaio; Guy S Salvesen
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

10.  Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.

Authors:  Domagoj Vucic; Matthew C Franklin; Heidi J A Wallweber; Kanad Das; Brendan P Eckelman; Hwain Shin; Linda O Elliott; Saloumeh Kadkhodayan; Kurt Deshayes; Guy S Salvesen; Wayne J Fairbrother
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.